- Home
- CLCO vs LFCR Comparison
CLCO vs LFCR Comparison
Compare CLCO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLCO
- LFCR
- Stock Information
- Founded
- CLCO 2018
- LFCR 1986
- Country
- CLCO United Kingdom
- LFCR United States
- Employees
- CLCO N/A
- LFCR N/A
- Industry
- CLCO
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CLCO
- LFCR Health Care
- Exchange
- CLCO Nasdaq
- LFCR Nasdaq
- Market Cap
- CLCO 360.2M
- LFCR 308.8M
- IPO Year
- CLCO N/A
- LFCR N/A
- Fundamental
- Price
- CLCO $7.44
- LFCR $7.37
- Analyst Decision
- CLCO
- LFCR Buy
- Analyst Count
- CLCO 0
- LFCR 4
- Target Price
- CLCO N/A
- LFCR $8.00
- AVG Volume (30 Days)
- CLCO 68.4K
- LFCR 125.1K
- Earning Date
- CLCO 08-28-2025
- LFCR 08-07-2025
- Dividend Yield
- CLCO 8.12%
- LFCR N/A
- EPS Growth
- CLCO N/A
- LFCR N/A
- EPS
- CLCO 1.31
- LFCR N/A
- Revenue
- CLCO $320,759,000.00
- LFCR $128,867,000.00
- Revenue This Year
- CLCO $2.10
- LFCR $4.10
- Revenue Next Year
- CLCO N/A
- LFCR $14.29
- P/E Ratio
- CLCO $5.63
- LFCR N/A
- Revenue Growth
- CLCO N/A
- LFCR 0.47
- 52 Week Low
- CLCO $4.51
- LFCR $3.68
- 52 Week High
- CLCO $12.41
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- CLCO 58.00
- LFCR 47.91
- Support Level
- CLCO $7.01
- LFCR $7.03
- Resistance Level
- CLCO $7.65
- LFCR $7.87
- Average True Range (ATR)
- CLCO 0.28
- LFCR 0.40
- MACD
- CLCO 0.01
- LFCR 0.01
- Stochastic Oscillator
- CLCO 69.57
- LFCR 53.70
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.